Therapeutic potential of salicylamide derivatives for combating viral infections
Medicinal Research Reviews · 2023-07 · 43 (4) · 897-931
DOI: 10.1002/med.21940 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Medicinal Research Reviews, online erschienen am 10.03.2023. Verfasst von Jimin Xu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Chemical Biology Program, Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX, USA. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 225 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NIAID NIH HHS, NIDA NIH HHS.
Abstract (Originalsprache)
Since time immemorial human beings have constantly been fighting against viral infections. The ongoing and devastating coronavirus disease 2019 pandemic represents one of the most severe and most significant public health emergencies in human history, highlighting an urgent need to develop broad‐spectrum antiviral agents. Salicylamide (2‐hydroxybenzamide) derivatives, represented by niclosamide and nitazoxanide, inhibit the replication of a broad range of RNA and DNA viruses such as flavivirus, influenza A virus, and coronavirus. Moreover, nitazoxanide was effective in clinical trials against different viral infections including diarrhea caused by rotavirus and norovirus, uncomplicated influenza A and B, hepatitis B, and hepatitis C. In this review, we summarize the broad antiviral activities of salicylamide derivatives, the clinical progress, and the potential targets or mechanisms against different viral infections and highlight their therapeutic potential in combating the circulating and emerging viral infections in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chemical Biology Program, Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX, USA.
- Department of Pharmacology and Toxicology, R. Ken Coit College of Pharmacy, University of Arizona, Tucson, Arizona, USA.
ORCID-Profile: Jia Zhou
Förderung
- NIH HHS
- NIAID NIH HHS
- NIDA NIH HHS
Zitieren
APA
Xu, J., Xue, Y., Bolinger, A. A., Li, J., Zhou, M., Chen, H., Li, H., & Zhou, J. (2023). Therapeutic potential of salicylamide derivatives for combating viral infections. Medicinal Research Reviews, 43(4), 897-931. https://doi.org/10.1002/med.21940
Vancouver
Xu J, Xue Y, Bolinger AA, Li J, Zhou M, Chen H, et al. Therapeutic potential of salicylamide derivatives for combating viral infections. Medicinal Research Reviews. 2023;43(4):897-931. doi:10.1002/med.21940
BibTeX
@article{Xu2023,
author = {Xu, Jimin and Xue, Yu and Bolinger, Andrew A and Li, Jun and Zhou, Mingxiang and Chen, Haiying and Li, Hongmin and Zhou, Jia},
title = {Therapeutic potential of salicylamide derivatives for combating viral infections},
journal = {Medicinal Research Reviews},
year = {2023},
volume = {43},
number = {4},
pages = {897--931},
doi = {10.1002/med.21940}
}
EUVIMED